Evidence map›Paper›PMID 33727821›Full record

ArticleJournal of multidisciplinary healthcare2021

Polypharmacy and Potential Drug-Drug Interactions in Home-Dwelling Older People - A Cross-Sectional Study.

Monica Hermann, Nina Carstens, Lars Kvinge, Astrid Fjell, Marianne Wennersberg, Kjersti Folleso, Knut Skaug, Ake Seiger, Berit Seiger Cronfalk, Anne-Marie Bostrom

Open access · goldAbstract read
In one paragraph

Article in Journal of multidisciplinary healthcare, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it, 39 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Observational
  9. Article
  10. Article
  11. Article
  12. Article
  13. Medication reconciliationEuropean journal of hospital pharmacy : science and practice · 2023
    Article
  14. Article
  15. Article
  16. Drug-Related Problems and Polypharmacy in Nursing Home Residents: A Cross-Sectional Study.International journal of environmental research and public health · 2022
    Observational
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 2 countries.

Monica HermannDepartment of Health and Caring Sciences, Western Norway University of Applied Sciences, Stord, Norway.ORCID 0000-0002-8006-3591
Nina CarstensHospital Pharmacies Enterprise, Western Norway, Bergen, Norway.
Lars KvingeDepartment of Health and Caring Sciences, Western Norway University of Applied Sciences, Stord, Norway.
Astrid FjellDepartment of Health and Caring Sciences, Western Norway University of Applied Sciences, Stord, Norway.ORCID 0000-0002-0531-1540
Marianne WennersbergFOUSAM, Western Norway University of Applied Sciences, Haugesund, Norway.
Kjersti FollesoBømlo Municipality, Hordaland, Norway.ORCID 0000-0002-9923-9788
Knut SkaugDepartment of Research and Innovation, Helse Fonna HF, Haugesund, Norway.
Ake SeigerDivision of Clinical Geriatrics, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden.
Berit Seiger CronfalkDepartment of Neurobiology, Care Sciences and Society, Division of Nursing, Karolinska Institutet, Stockholm, Sweden.
Anne-Marie BostromDepartment of Health and Caring Sciences, Western Norway University of Applied Sciences, Stord, Norway.ORCID 0000-0002-9421-3941
Western Norway University of Applied Sciences · NOKarolinska Institutet · SEFonna Hospital TrustHordaland County Council · NOKarolinska University Hospital · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundRisks associated with polypharmacy and drug-drug interactions represent a challenge in drug treatment, especially in older adults. The aim of the present study was to assess the use of prescription and non-prescription drugs and the frequency of potential drug-drug interactions in home-dwelling older individuals.

methodsA cross-sectional study design was applied. Data were collected during preventive home visits among individuals aged ≥75 in three separate communities of Western Norway. A questionnaire, which was filled out by the individual, their next-of-kin, and the nurse performing the home visit was used for the collection of demographic and clinical data (age, sex, medication use, diagnoses, need of assistance with drug administration). Potential drug-drug interactions were identified electronically by IBM Micromedex Drug Interaction Checking. Point prevalence of potential drug-drug interactions and polypharmacy (≥5 drugs) were calculated. Binary logistic regression analyses were performed to assess factors potentially associated with polypharmacy or potential drug-drug interactions.

resultsAmong the 233 individuals (mean age 78±3 years, 46% male) included in the study, 43% used ≥5 drugs, 3.4% ≥10 drugs, while 4.3% used no drugs. In 54% of the 197 individuals using two or more drugs, at least one potential drug-drug interaction was detected. Low-dose aspirin and simvastatin were most frequently involved in potential drug-drug interactions. In total, 25% of the individuals reported current use of drugs sold over the counter of which more than 95% were analgesic drugs. Potential drug-drug interactions involving ibuprofen were identified in nine of 11 (82%) individuals using over-the-counter ibuprofen.

conclusionThe study revealed a high prevalence of polypharmacy and potential drug-drug interactions with both prescription and non-prescription drugs in older home-dwelling individuals. Close monitoring of the patients at risk of drug-drug interactions, and increased awareness of the potential of over-the-counter drugs to cause drug-drug interactions, is needed.

Indexed as

drug–drug interactionshome-dwellingold peoplepolypharmacy

Identifiers

PMID33727821
PMCPMC7955724
OpenAlexW3133510631

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.